Related Experiment Video
Updated: Jun 23, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Pediatric HIV immune reconstitution inflammatory syndrome
David R Boulware1, Steven Callens, Savita Pahwa
1Infectious Diseases and International Medicine, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, Minneapolis, Minnesota, USA. Boulw001@umn.edu
Purpose Of Review:
Little is known regarding HIV immune reconstitution inflammatory syndrome in children. As the antiretroviral therapy roll out has gathered pace since 2004 in resource-limited settings, pediatric immune reconstitution inflammatory syndrome has emerged as a clinical challenge.
Recent Findings:
The incidence of immune reconstitution inflammatory syndrome appears to be between 10 and 20%. The commonest causes are mostly mycobacterial, including tuberculosis, atypical mycobacteria and bacillus Calmette-Guérin related. In many pediatric cohorts, however, a marked early mortality within the first 90 days of antiretroviral therapy occurs. This mortality is poorly understood, and the contribution of immune reconstitution inflammatory syndrome to this mortality is unknown.
Summary:
Children after starting antiretroviral therapy may have paradoxical worsening of previously treated opportunistic infections. Due to the differences, however, in children's immunology with vertical HIV transmission, children are probably at greater risk of unmasking occult, subclinical infections during immune reconstitution.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Respiratory Syncytial Virus Disease
Pharmacokinetics in Pediatric Patients: Drug Excretion
Sexually Transmitted Infections
Retrovirus Life Cycles
Cytomegalovirus Disease

